The Relationship Between GBS Screening in Pregnant Women Insured in Maccabi Healthcare Services (MHS) and Early-onset Neonatal Disease in Israel

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04222907

Enrollment

54759

Registered

2020-01-10

Start date

2015-01-01

Completion date

2019-09-20

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Streptococcal Infection Group B as Cause of Diseases Classified Elsewhere (Diagnosis)

Brief summary

Determination of GBS colonization rates in Pregnant Women insured with Maccabi Health Services, Doctors' Compliance Rates for Referral for Testing, test execution rates, and Early-onset GBS Disease (EOGBSD) Rates in Israel. Determine the relationship between conducting a GBS test in pregnant women and EOGBSD in Israel.

Detailed description

There have been few studies in recent years, which has prompted us to undertake this study. Our aim was to examine the current colonization rates and attack rates in the Israeli population. Our secondary aim was to evaluate the need to readjust recommendations towards universal screening.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

OTHER

Eligibility

Sex/Gender

FEMALE

Inclusion criteria

* All women with term pregnancies from 2015 to 2016 (until 20/9/16) insured by Maccabi Healthcare Services (MHS)

Exclusion criteria

* repeat pregnancies occurring in the same woman during the time period * multiple pregnancies * gestational age greater than 42 weeks due to probability of data inaccuracy * women with missing information

Design outcomes

Primary

Measure	Time frame	Description
Attack rate of early-onset GBS disease (EOGBSD)	2015-2016	Attack rate of (EOGBSD)

Outcome results